ArticleBiotechnology and bioengineering2026

Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived Protein.

Frances Rocamora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.